First-onset tics in patients with attention-deficit-hyperactivity disorder: Impact of stimulants

Developmental Medicine and Child Neurology

Volumn 48, Issue 7, 2006, Pages 616-621

  Roessner, Veit ^a   Robatzek, Monika ^a   Knapp, Guido ^b   Banaschewski, Tobias ^a   Rothenberger, Aribert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHILD; CHILD DEVELOPMENT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS; METHODOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TIC;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RISK FACTORS; TIC DISORDERS; TICS;

EID: 33745227370     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1017/S0012162206001290     Document Type: Review

References (64)

1. Rothenberger A, Döpfner M, Sergeant S, Steinhausen H-C. (2004) ADHD - beyond core symptoms. Eur Child Adolesc Psychiatry 13 (Suppl 1).
2. Biederman J, Faraone SV. (2005) Attention-deficit-hyperactivity disorder. Lancet 366: 237-248.
3. Gillberg C, Gillberg IC, Rasmussen P, Kadesjo B, Soderstrom H, Rastam M, Johnson M, Rothenberger A, Niklasson L. (2004) Co-existing disorders in ADHD-implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13 (Suppl 1): 180-192.
4. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. (2001) Tourette disorder and ADHD. Adv Neurol 85: 57-77.
5. Leckman JF. (2002) Tourette's syndrome. Lancet 360: 1577-1586.
6. Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA. (1982) Stimulant medications precipitate Tourette's syndrome. JAMA 247: 1168-1169.
7. Cohen DJ, Leckman JF. (1989) Commentary on 'Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.' J Am Acad Child Adolesc Psychiatry 28: 580-582.
8. Shapiro AK, Shapiro E. (1981) Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Compr Psychiatry 22: 265-273.
9. Kurlan R. (2003) Tourette's syndrome: Are stimulants safe? Curr Neurol Neurosci Rep 3: 285-288.
10. Bachman DS. (1981) Pemoline-induced Tourette's disorder: A case report. Am J Psychiatry 138: 1116-1117.
11. Bonthala CM, West A. (1983) Pemoline induced chorea and Gilles de la Tourette's syndrome. Br J Psychiatry 143: 300-302.
12. Bremness AB, Sverd J. (1979) Methylphenidate-induced Tourette syndrome: case report. Am J Psychiatry 136: 1334-1335.
13. Golden GS. (1974) Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 16: 76-78.
14. Pollack MA, Cohen NL, Friedhoff AJ. (1977) Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol 34: 630-632.
15. Golden GS. (1977) The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol 2: 69-70.
16. Law SF, Schachar RJ. (1999) Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 38: 944-951.
17. Varley CK, Vincent J, Varley P, Calderon R. (2001) Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Compr Psychiatry 42: 228-233.
18. Denckla MB, Bemporad JR, MacKay MC. (1976) Tics following methylphenidate administration. A report of 20 cases. JAMA 235: 1349-1351.
19. Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J. (1990) Motor/ vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Res 33: 83-94.
20. Sprafkin J, Gadow KD. (1993) Four purported cases of methylphenidate-induced tic exacerbation: Methodological and clinical doubts. J Child Adolesct Psychopharmacology 3: 231-244.
21. Khalifa N, von Knorring AL. (2003) Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 45: 315-319.
22. Lanzi G, Zambrino CA, Termine C, Palestra M, Ferrari Ginevra O, Orcesi S, Manfredi P, Beghi E. (2004) Prevalence of tic disorders among primary school students in the city of Pavia, Italy. Arch Dis Child 89: 45-47.
23. Wang HS, Kuo MF. (2003) Tourette's syndrome in Taiwan: An epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev 25 (Suppl 1): S29-S31.
24. Torup E. (1962) A follow-up study of children with tics. Acta Paediatr 51: 261-268.
25. Khalifa N, von Knorring AL. (2003) Prevalence of tic disorders and Tourette syndrome in a Swedish school population. 45: 315-319.
26. Snider LA, Seligman LD, Ketchen BR, Levitt SJ, Bates LR, Garvey MA, Swedo SE. (2002) Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 110 (2 Pt 1): 331-336.
27. Peterson BS, Pine DS, Cohen P, Brook JS. (2001) Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/ hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 40: 685-695.
28. Erenberg G, Cruse RP, Rothner AD. (1985) Gilles de la Tourette's syndrome: Effects of stimulant drugs. Neurology 35: 1346-1348.
29. Tourette Syndrome Study Group. (2002) Treatment of ADHD in children with tics: A randomized controlled trial. Neurology 58: 527-536.
30. Schachter HM, Pham B, King J, Langford S, Moher D. (2001) How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 165: 1475-1488.
31. Ghuman JK, Ginsburg GS, Subramaniam G, Ghuman HS, Kau AS, Riddle MA. (2001) Psychostimulants in preschool children with attention-deficit/ hyperacuvity disorder: Clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry 40: 516-524.
32. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. (2003) ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 42: 424-433.
33. Campbell M, Palij M. (1985) Measurement of side-effects including tardive dyskinesia. Psychopharmacol Bull 21: 1063-1080.
34. Pelham WE. (1993) Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psych Rev 22: 199-227.
35. Manos MJ. (1996) Side Effects/Behaviour Monitoring Scale. Cleveland: Cape Western Reserve University School of Medicine, Department of Psychiatry.
36. Palumbo D, Spencer T, Lynch J, Co-Chien H, Faraone SV. (2004) Emergence of tics in children with ADHD: Impact of once-daily OROS methylphenidate therapy. J Child Adolesc Psychopharmacol 14: 185-194.
37. Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B, Eidevall-Wallin L, Gustafsson P, Kopp S. (1997) Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 54: 857-864.
38. Kurlan R. (2002) Methylphenidate to treat ADHD is not contraindicated in children with tics. Mov Disord 17: 5-6.
39. Smith BH, Pelham WE, Evans S, Gnagy E, Molina B, Bukstein O, Greiner A, Myak C, Presnell M, Willoughby M. (1998) Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention-deficit hyperactivity disorder. Exp Clin Psychopharmacol 6: 187-204.
40. Angold A, Erkanli A, Egger HL, Costello EJ. (2000) Stimulant treatment for children: A community perspective. J Am Acad Child Adolesc Psychiatry 39: 975-984. (Discussion 984-994)
41. Lipkin PH, Goldstein IJ, Adesman AR. (1994) Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 148: 859-861.
42. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. (1990) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics 86: 184-192.
43. Doherty SL, Frankenberger W, Fuhrer R, Snider V. (2000) Children's self-reported effects of stimulant medication. Int J Disabil Dev Educ 47: 39-54.
44. Dulcan MK, Benson RS. (1997) AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry 86: 1311-1317.
45. Castellanos FX. (1999) Stimulants and tic disorders: From dogma to data. Arch Gen Psychiatry 56: 337-338.
46. Comings DE, Comings BG. (1984) Tourette's syndrome and attention deficit disorder with hyperactivity: Are they genetically related? J Am Acad Child Psychiatry 23: 138-146.
47. Comings DE, Comings BG. (1987) A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 41: 701-741.
48. Taylor FB, Russo J. (2000) Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 10: 311-320.
49. Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S. (1999) The 4-year course of tic disorders in boys with attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 56: 842-847.
50. Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH. (2003) A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 112: E404.
51. Kooij JJ, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 84: 973-982.
52. Pauls DL, Leckman JF. (1986) The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med 315: 993-997.
53. Pauls DL, Leckman JF, Cohen DJ. (1993) Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 32: 1044-1050.
54. Price RA, Leckman JF, Pauls DL, Cohen DJ, Kidd KK. (1986) Gilles de la Tourette's syndrome: Tics and central nervous system stimulants in twins and nontwins. Neurology 36: 232-237.
55. Roessner V, Becker A, Banaschewski T, Rothenberger A. (2005) Tic disorders and obsessive compulsive disorder: Where is the link? J Neural Transm Suppl 69: 69-99.
56. Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S. (1998) Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J Child Adolesc Psychopharmacol 8: 13-25.
57. Rapport MD, Randall R, Moffitt C. (2002) Attention-deficit/hyperactivity disorder and methylphenidate: A dose-response analysis and parent-child comparison of somatic complaints. J Atten Disord 6: 15-24.
58. Quinn D, Wigal S, Swanson J, Hirsch S, Ottolini Y, Dariani M, Roffman M, Zeldis J, Cooper T. (2004) Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43: 1422-1429.
59. Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-Maclean L, Morse G. (2005) A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry 44: 522-529.
60. Smithee JA, Klorman R, Brumaghim JT, Borgstedt AD. (1998) Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder. J Abnorm Child Psychol 26: 233-245.
61. Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, Altenderfer L, Baron-Myak C. (2001) Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 9: 163-175.
62. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD. (2001) Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107: E105.
63. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G. (2001) Randomized, controlled trial of oral methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 108: 883-892.
64. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S. (2003) Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: Proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 60: 204-211.